Delivery Order SPM20005D1110-CC49
- Not listed
- This federal contract award is for a delivery order under a TRICARE North healthcare contract with the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $95,366.00 and is a firm fixed-price delivery order with no set-aside designation, indicating open competition. The contract supports the...
- This federal contract award is for a $91,314.14 delivery order under the TRICARE North contract, issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of a range of pharmaceutical products and medical supplies, including specialty medications, generic drugs, brand-name pharmaceuticals, medical devices, and other essential medical commodities. The contract does not have a set-aside...
- The federal contract award is for the delivery of a wide range of pharmaceutical products and medical supplies to support the TRICARE North healthcare program, which is managed by the Defense Logistics Agency (DLA) Troop Support Medical. The primary contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $80,582.22 and a completion date of April 20, 2015. The...
- This federal contract award, valued at $83,046.23, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $114,712.94, is a Firm Fixed Price Delivery Order that will support the TRICARE North healthcare program. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $125,438.26 delivery order contract is for the provision of various pharmaceutical products and medical supplies to support the TRICARE North healthcare program. The contract is a firm fixed-price agreement and does not have a set-aside designation, indicating open competition....
- This federal contract award is for a delivery order with a ceiling value of $82,360.26, awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a firm fixed-price arrangement to provide TRICARE North medical supplies. The ultimate completion date is April 2, 2015. Amerisourcebergen is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $78,364.50, is a Firm Fixed Price Delivery Order for the provision of TRICARE medical supplies to support the DLA's healthcare programs. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery...
- This federal contract award is for the delivery of pharmaceutical products and medical supplies to support the TRICARE West healthcare program under the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $88,057.02 and is a firm fixed-price delivery order. It does not have a set-aside designation, indicating open competition....
- This federal contract award is a delivery order with a ceiling value of $128,877.27, issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is for the provision of a broad range of pharmaceutical products, medical supplies, and devices to support TRICARE, the military healthcare program. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major...
- SPM20005D1110Indefinite Delivery Contract
- SPM20005D1110-CC49Delivery Order
This federal contract award is for a Delivery Order under the TRICARE North Contract, valued at $144,710.38. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense, and is for the provision of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for delivering essential medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, and test kits across various therapeutic areas. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $144.7k | 4/13/15 |